0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Strengths available for Denosumab vial:

Denosumab vial 60mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Denosumab:

  • Argentina
  • Austria
  • Azerbaijan
  • Bangladesh
  • Bosnia and Herzegovina
  • Cayman Islands
  • Chile
  • China
  • Cuba
  • Cyprus
  • Ecuador
  • Greenland
  • Guadeloupe
  • Guam
  • Honduras
  • Hungary
  • India
  • Iran
  • Iraq
  • Korea, South
  • Latvia
  • Liechtenstein
  • Moldova, Republic of
  • Norway
  • Panama
  • Poland
  • Portugal
  • Saudi Arabia
  • Serbia
  • Singapore
  • South Africa
  • Spain
  • Thailand
  • Tonga
  • Trinidad and Tobago
  • Ukraine
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
  • Uruguay
View All Countries

Latest news releases on Denosumab:

Denosumab - Wikipedia

Denosumab (trade names Prolia and Xgeva) is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.

Denosumab - Wikipedia

Il denosumab, commercializzato con i nomi Prolia e Xgeva, è un anticorpo monoclonale completamente umanizzato indicato per il trattamento dell'osteoporosi post-menopausale (PMO) ed il rimaneggiamento con perdita di massa ossea per artrite reumatoide (AR) o metastasi ossee.

Denosumab (Prolia, Xgeva) | Cancer drugs | Cancer Research UK

Denosumab (Prolia, Xgeva) Read about denosumab, how you have it and other important information about taking this cancer drug. Denosumab (pronounced den-oh-sue-mab) is a type of targeted therapy called a monoclonal antibody.

Prolia - pro.medicin.dk – information om medicin

Hypocalcæmi og D-vitaminmangel skal korrigeres inden behandlingsstart, og P-calcium bør kontrolleres forud for den halvårlige injektion. Behandlingen suppleres med et dagligt oralt tilskud af 400-1.000 mg calcium i kombination med 20-40 mikrogram D-vitamin.

Denosumab - DocCheck Flexikon

1 Definition. Denosumab ist ein monoklonaler Antikörper aus der Gruppe der RANK-Ligand-Inhibitoren, der zur Therapie der Osteoporose eingesetzt wird.

Bone Metastases from Solid Tumors | XGEVA® (denosumab ...

Close. XGEVA ® is a prescription medicine used to prevent fracture, spinal cord compression, or the need for radiation or surgery to bone in patients with multiple myeloma and in patients with bone metastases from solid tumors.

Denosumab: informe técnico - info-farmacia

APROBACIÓN DE DENOSUMAB.-Denosumab fue autorizado por la FDA con fecha 1 de junio de 2010, solo una semana más tarde de la aprobación por la Agencia Europea del Medicamento (EMEA, de su acrónimo en inglés).

Substans - FASS Allmänhet

Cookies Den här webbplatsen använder så kallade cookies. Cookies är små textfiler som lagras i din dator och sparar information om olika val som du gjort på en webbsida – t ex språk, version och statistik – för att du inte ska behöva göra dessa val en gång till.

Denosumab - Informazioni sui farmaci

Siringa preriempita contenente 60 mg di denosumab in 1 ml di soluzione € 312,79 Conservare in frigorifero (2°-8°C) Classe A Continuità Terapeutica Ospedale-Territorio con Diagnosi e Piano Terapeutico.

PharmaWiki - Denosumab

Denosumab Arzneimittelgruppen Monoklonale Antikörper RANKL-Inhibitoren Denosumab ist ein Wirkstoff aus der Gruppe der monoklonalen Antikörper, der für die Behandlung der Osteoporose eingesetzt wird.

Customer Service
1-866-799-3435 - Use ref# 7500 | Contact Form
Copyright © 2018 ExpressMedsCanada.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK